KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Cash from Operations (2016 - 2025)

Pfizer (PFE) has disclosed Cash from Operations for 17 consecutive years, with 5348000000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations changed N/A to 5348000000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 11704000000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at 11704000000.0 for FY2025, 8.16% down from the prior year.
  • Cash from Operations for Q4 2025 was 5348000000.0 at Pfizer, up from 4603000000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 26666000000.0 in Q4 2021, with the low at 1781000000.0 in Q2 2024.
  • Average Cash from Operations over 5 years is 6096176470.59, with a median of 4603000000.0 recorded in 2025.
  • The sharpest move saw Cash from Operations soared 319.01% in 2021, then crashed 114.79% in 2023.
  • Over 5 years, Cash from Operations stood at 26666000000.0 in 2021, then dropped by 22.43% to 20685000000.0 in 2022, then crashed by 74.67% to 5240000000.0 in 2023, then increased by 14.94% to 6023000000.0 in 2024, then dropped by 11.21% to 5348000000.0 in 2025.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 5348000000.0, 4603000000.0, and 582000000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.